Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32103003.
- Also identified by DOI 10.1038/s41467-020-14697-z and PMC identifier 7044294.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Pogo transposable element derived with ZNF domain (POGZ) has been identified as one of the most recurrently de novo mutated genes in patients with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), intellectual disability and White-Sutton syndrome; however, the neurobiological basis behind these disorders remains unknown. Here, we show that POGZ regulates neuronal development and that ASD-related de novo mutations impair neuronal development in the developing mouse brain and induced pluripotent cell lines from an ASD patient. We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice. Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice. Our results provide insight into how de novo mutations on high-confidence ASD genes lead to impaired mature cortical network function, which underlies the cellular pathogenesis of NDDs, including ASD.
Medical subject headings
- Autistic Disorder
- Genetic Predisposition to Disease
- Malformations of Cortical Development
- Mutation
- Phenotype
- Transposases